Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07625592

Co-design of an AI Rehabilitation Program for Children With Borderline Intellectual Disorder

Co-design of an AI Rehabilitation Program for Children With Borderline Intellectual Disorder

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Borderline Intellectual Functioning (BIF) Intellectual Disability Mental Disorders Nervous System Diseases Neurobehavioral Manifestations Neurodevelopmental Disorders Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

7 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Samsung Medical Center

Seoul, 06351, South Korea

About this study

This study aims to co-design a tablet-based artificial intelligence (AI) cognitive and language rehabilitation program for school-aged children with borderline intellectual disorder using an experience-based collaborative design (EBCD) approach. Children with prior experience using the program, their legal guardians, and relevant professionals will participate in interviews and collaborative workshops to identify user needs and improve program usability.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • School-aged children aged 7 to under 16 years with borderline intellectual disorder who have experienced the tablet-based AI cognitive and language rehabilitation program at least once
  • Legal guardians of eligible children
  • Developers of the AI rehabilitation program or professionals with expertise in cognition, language, learning, or rehabilitation for children with borderline intellectual disorder

Exclusion criteria

  • Individuals who are unable to participate in interviews or workshops due to communication difficulties or inability to provide informed consent/assent

Treatment and study plan

Tablet-Based AI Cognitive and Language Rehabilitation Program

Behavioral

A tablet-based artificial intelligence (AI) cognitive and language rehabilitation program previously experienced by children with borderline intellectual disorder. The study collects user and provider experiences through interviews and collaborative workshops to support experience-based co-design and program improvement.

Primary outcomes

  1. Qualitative Themes Regarding Participant Experiences with the AI Rehabilitation Program

    Time frame: Once per participant/professional during the interview or workshop session conducted post-intervention (overall data collection through December 2026).

    Qualitative themes regarding participant experiences with the tablet-based AI cognitive and language rehabilitation program will be identified. In-depth interviews will be conducted with users with borderline intellectual functioning and their legal guardians to explore usability and satisfaction. Additionally, focus group discussions with developers and clinical professionals will be held to gather multidisciplinary insights. All qualitative data will be analyzed using qualitative content analysis to extract key core themes. Therefore, there is no quantitative scale used. Results will be reported as identified thematic categories.

Secondary outcomes

  1. Perceived Barriers and Challenges to AI Rehabilitation Program Use

    Time frame: Once per participant/professional during the interview or workshop session conducted post-intervention (overall data collection through December 2026).

    Participant-perceived barriers and challenges related to the use of the tablet-based AI cognitive and language rehabilitation program will be identified. Through semi-structured qualitative interviews with users with borderline intellectual functioning and their legal guardians, as well as focus group discussions with developers and clinical professionals, potential obstacles to program adherence, technical difficulties, and clinical limitations will be explored. All qualitative data will be analyzed using thematic analysis to extract core barrier themes. Therefore, there is no quantitative scale used. Results will be reported as identified thematic categories.

  2. Co-design Recommendations for AI Rehabilitation Program Improvement

    Time frame: Once per participant/professional during the co-design workshop sessions conducted during the study period (overall data collection through December 2026).

    Recommendations for the improvement and optimization of the tablet-based AI cognitive and language rehabilitation program will be developed. Through collaborative co-design workshops involving users with borderline intellectual functioning, their legal guardians, developers, and clinical professionals, actionable insights regarding feature enhancements and interface modifications will be explored. All qualitative data gathered from the workshops will be analyzed using thematic analysis to synthesize core design recommendations. Therefore, there is no quantitative scale used. Results will be reported as identified thematic categories and recommendation frameworks.

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Official study title

Multidisciplinary Experience-Based Collaborative Design (Co-design) Study of a Tablet-Based AI Cognitive and Language Rehabilitation Program for School-Aged Children With Borderline Intellectual Disorder

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 4, 2026
Registry last updated
Jun 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.